ArticleClinical and experimental medicine2023

Correction to: Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma.

Linping Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.